Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan-Dec:29:10732748221142750.
doi: 10.1177/10732748221142750.

Surgical Treatment is Still Recommended for Patients Over 75 Years with IA NSCLC: A Predictive Model Based on Surveillance, Epidemiology and End Results Database

Affiliations

Surgical Treatment is Still Recommended for Patients Over 75 Years with IA NSCLC: A Predictive Model Based on Surveillance, Epidemiology and End Results Database

Wenting Zhang et al. Cancer Control. 2022 Jan-Dec.

Abstract

Background: To determine the populations who suitable for surgical treatment in elderly patients (age ≥ 75 y) with IA stage.

Methods: The clinical data of NSCLC patients diagnosed from 2010 to 2015 were collected from the SEER database and divided into surgery group (SG) and no-surgery groups (NSG). The confounders were balanced and differences in survival were compared between groups using PSM (Propensity score matching, PSM). Cox regression analysis was used to screen the independent factors that affect the Cancer-specific survival (CSS). The surgery group was defined as the patients who surgery-benefit and surgery-no benefit according to the median CSS of the no-surgery group, and then randomly divided into training and validation groups. A surgical benefit prediction model was constructed in the training and validation group. Finally, the model is evaluated using a variety of methods.

Results: A total of 7297 patients were included. Before PSM (SG: n = 3630; NSG: n = 3665) and after PSM (SG: n = 1725, NSG: n = 1725) confirmed that the CSS of the surgery group was longer than the no-surgery group (before PSM: 82 vs. 31 months, P < .0001; after PSM: 55 vs. 39 months, P < .0001). Independent prognostic factors included age, gender, race, marrital, tumor grade, histology, and surgery. In the surgery cohort after PSM, 1005 patients (58.27%) who survived for more than 39 months were defined as surgery beneficiaries, and the 720 patients (41.73%) were defined surgery-no beneficiaries. The surgery group was divided into training group 1207 (70%) and validation group 518 (30%). Independent prognostic factors were used to construct a prediction model. In training group (AUC = .678) and validation group (AUC = .622). Calibration curve and decision curve prove that the model has better performance.

Conclusions: This predictive model can well identify elderly patients with stage IA NSCLC who would benefit from surgery, thus providing a basis for clinical treatment decisions.

Keywords: Non-small cell lung cancer; SEER database; nomogram; predictive model; surgery.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure
1.
Figure 1.
Flow chart of predictive model construction.
Figure
2.
Figure 2.
Kaplan–Meier plots show the specific survivals of NSCLC patients according to the group before PSM (A) or after PSM (B).
Figure
3.
Figure 3.
Univariate Cox regression analysis of factors affecting CSS.
Figure
4.
Figure 4.
Multivariate Cox regression analysis of factors affecting CSS.
Figure
5.
Figure 5.
Nomogram was used to identify patients with NSCLC who would benefit from surgery.
Figure
6.
Figure 6.
Receiver operating characteristic curve of the nomogram in the training (A) and validation (D) groups. (B) The calibration plots of the training group. (E) The calibration plots of the validation group. Decision curve analysis of training group (C) and validation group (F).
Figure 7.
Figure 7.
Kaplan–Meier analysis of a comparison of benefit candidates, no-benefit candidates and no-surgery patients in the training group (A) and validation group (B) after using our nomogram.

References

    1. Smeltzer MP, Lee YS, Faris MDN, et al. Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected NSCLC in a High Mortality Area of the United States. J Thorac Oncol, 2021,16(10):1663-1671. - PMC - PubMed
    1. Flores R, Patel P, Alpert N, et al. Association of stage shift and population mortality among patients with non-small cell lung Cancer. JAMA Netw Open, 2021,4(12):e2137508. - PMC - PubMed
    1. Sroufe R, Kong FM. Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what? Transl Lung Cancer Res, 2015,4(4):438-447. - PMC - PubMed
    1. Shimoyama R, Tsutani Y, Wakabayashi M, et al. A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study). Jpn J Clin Oncol, 2020,50(10):1209-1213. - PubMed
    1. Hao B, Fan T, Xiong J, et al. The prognostic significance of the histological types in patients with nonsmall cell lung Cancer </=2 cm. Front Surg, 2021,8:721567. - PMC - PubMed